Patients discharged without test results

Close to half of the tests ordered by doctors on the day of a patient's discharge from hospital are not looked at again, UNSW research has found.

Professor Enrico Coiera, Director of the Centre for at the Australian Institute of Health Innovation at UNSW, led the study which is published today in The .

He says some of the tests that are ordered may be unnecessary, while those that are clinically significant should be followed up.

“At the most extreme, tests that are ordered on the day a patient is discharged from hospital have the least time available for them to be looked at,” Professor Coiera says.

“We found that it is especially these tests, ordered on discharge day, where the biggest problem lies. So while the tests ordered on discharge day only accounted for about 7% of all tests ever ordered in our study, they were responsible for 47% of unread tests at the time of discharge, and 41% of unread tests two months after discharge.”

His team recommends a number of potential ways to attack the problem, with specific reference to computerised test ordering systems.

“Even a simple list of test results that have not yet been read or have not yet come in could be generated electronically to prompt clinical teams to actively manage them, both on discharge day and in the days that follow,” he says.

add to favorites email to friend print save as pdf

Related Stories

Fumbled handoffs can lead to medical errors

Aug 07, 2009

Poor communication of the outcomes of medical tests whose results are pending at the time of a patient's hospital discharge is common and can lead to serious medical errors in post-hospitalization medical treatment.

Asymptomatic often sent for lung cancer screening tests

Mar 13, 2012

(HealthDay) -- A majority of primary care physicians report ordering lung cancer screening tests for asymptomatic patients, according to research published in the March/April issue of the Annals of Family Me ...

Recommended for you

German Merck to buy St. Louis-based Sigma-Aldrich

Sep 22, 2014

German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion in a deal Merck says will strengthen its business in chemicals and laboratory equipment.

The human race evolved to be fair for selfish reasons

Sep 19, 2014

"Make sure you play fairly," often say parents to their kids. In fact, children do not need encouragement to be fair, it is a unique feature of human social life, which emerges in childhood. When given the o ...

User comments